|
業務類別
|
Biotechnology |
|
業務概覽
|
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3K. Its flagship program is OKI-219. The company operates in one operating segment: clinical research. |
| 公司地址
| 6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301 |
| 電話號碼
| +1 720 307-2892 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.onkuretherapeutics.com |
| 員工數量
| 45 |
| Dr. Dylan Hartley, PhD |
Chief Scientific Officer |
-- |
21/04/2026 |
| Dr. Samuel Agresta, M.D.,M.P.H. |
Chief Medical Officer |
美元 482.00K |
21/04/2026 |
| Dr. Nicholas A. Saccomano, PhD |
Director, President and Chief Executive Officer |
美元 600.00K |
21/04/2026 |
| Mr. Jason A. Leverone |
Chief Financial Officer and Principal Accounting Officer |
美元 444.00K |
21/04/2026 |
| Dr. Isaac Manke, PhD |
Director and Senior Vice President, Business Development |
-- |
21/04/2026 |
|
|
| Dr. Liam Ratcliffe, M.B.,M.B.A.,PhD |
Independent Director |
21/04/2026 |
| Dr. Andrew Phillips, PhD |
Chairman of the Board |
21/04/2026 |
| Mr. Michael Grey |
Director |
21/04/2026 |
| Mr. Edward T. Mathers |
Independent Director |
21/04/2026 |
| Dr. Liam Ratcliffe |
Director |
30/03/2026 |
| Ms. Valerie Malyvanh Jansen, M.D.,PhD |
Independent Director |
21/04/2026 |
| Dr. Nicholas A. Saccomano, PhD |
Director, President and Chief Executive Officer |
21/04/2026 |
| Mr. R. Michael Carruthers |
Independent Director |
21/04/2026 |
| Dr. Isaac Manke, PhD |
Director and Senior Vice President, Business Development |
21/04/2026 |
|
|
|
|
